AstraZeneca (NYSE:AZN) today announced that it is simplifying the enrollment process for the AZ&Me™ Prescription Savings Program for people with Medicare Part D by removing an out-of-pocket spend requirement. As of Jan. 1, the program will no longer require that people with Medicare prescription drug coverage spend 3 percent of their annual household income on out-of-pocket costs for prescription medicines within the calendar year to qualify. Those who meet all of the other program eligibility requirements may begin receiving their AstraZeneca medicines for free upon successfully completing the enrollment process. To be eligible for the program, a Medicare beneficiary must:
- Be enrolled in Medicare Part D.
- Have an annual household income at or below $35,000 for individuals or $48,000 for couples.
- Not be enrolled in the Medicare Limited Income Subsidy.
For a list of medicines covered under Medicare Part D, visit http://www.astrazeneca-us.com/medicines/help-affording-your-medicines/list-of-covered-medicines.- ENDS - About AstraZeneca AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information about AstraZeneca in the U.S. or our AZ&Me™ Prescription Savings programs, please visit: www.astrazeneca-us.com or call 1-800-AZandMe (292-6363).